MARKET

RLYB

RLYB

Rallybio Corp
NASDAQ
0.2500
-0.0018
-0.71%
After Hours: 0.2592 +0.0092 +3.68% 16:36 04/17 EDT
OPEN
0.2442
PREV CLOSE
0.2518
HIGH
0.2593
LOW
0.2439
VOLUME
27.81K
TURNOVER
--
52 WEEK HIGH
2.010
52 WEEK LOW
0.2201
MARKET CAP
10.40M
P/E (TTM)
-0.1884
1D
5D
1M
3M
1Y
5Y
1D
This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Benzinga · 5d ago
Rallybio Cut to Hold From Buy by Jones Trading
Dow Jones · 5d ago
Jones Trading Downgrades Rallybio to Hold
Benzinga · 5d ago
U.S. RESEARCH ROUNDUP- CNB Financial, Disney, Triumph Group
Reuters · 5d ago
RALLYBIO CORP <RLYB.O>: JONESTRADING CUTS TO HOLD FROM BUY
Reuters · 5d ago
Rallybio downgraded to Hold from Buy at JonesResearch
TipRanks · 5d ago
Weekly Report: what happened at RLYB last week (0407-0411)?
Weekly Report · 6d ago
Rallybio downgraded to In Line from Outperform at Evercore ISI
TipRanks · 04/11 19:55
More
About RLYB
Rallybio Corporation is a clinical-stage biotechnology company engaged in developing and commercializing life-transforming therapies for patients with severe and rare diseases. It has a pipeline of product candidates aimed at addressing diseases with unmet medical needs in the areas of maternal fetal health, complement dysregulation, hematology, and metabolic disorders. It has two clinical-stage programs: RLYB212, an anti-HPA-1a antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and RLYB116, an inhibitor of complement component 5 (C5), with the potential to treat several diseases of complement dysregulation, as well as additional programs in preclinical development. Its other product candidates include RLYB114, is a C5-targeted Affibody molecule conjugated to polyethylene glycol; RLYB332, is a preclinical antibody designed to inhibit MTP-2, and REV102 Program, is a small molecule inhibitor of ectonucleotide pyrophosphatase/ phosphodiesterase 1(ENPP1).

Webull offers Rallybio Corp stock information, including NASDAQ: RLYB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RLYB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RLYB stock methods without spending real money on the virtual paper trading platform.